MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$51K
Net Income
-$7,272K
Net Profit Margin
-14258.82%
EPS
-$0.07
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenues
51
39
75
42
Cost of goods sold
278
313
211
203
Research and development
3,132
3,642
4,553
2,700
Sales and marketing
181
164
96
405
General and administrative
2,029
1,879
1,600
2,442
Total costs and operating expenses
5,620
5,998
6,460
5,750
Operating loss
-5,569
-5,959
-6,385
-5,708
Change in fair value of forward purchase agreement warrant liability
-23
13
-12
-64
Change in fair value of forward purchase agreement warrant liability due to extension
-
-
6*
-
Change in fair value of private warrant liability
-
-
-
339
Loss on offering and change in fair value of private warrant liability
838
-2,005
173*
-
Change in fair value of publicly traded warrant liability
-236
390
18
33
Interest expense (related party)
-
0
0
471
Other income (expense), net
166
6
-16
5
Total other income (expense), net
-413
1,608
-201
-774
Net loss
-5,982
-4,351
-6,586
-6,482
Cumulative preferred dividends
1,290
1,350
1,151
1,265
Net loss attributable to common stockholders, basic
-7,272
-5,701
-7,737
-7,747
Basic EPS
-0.07
-0.08
-0.272
-0.35
Diluted EPS
-0.07
-0.08
-0.272
-0.35
Basic Average Shares
104,039,109
68,934,960
28,476,325
21,851,606
Diluted Average Shares
104,039,109
68,934,960
28,476,325
21,851,606
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$7,272K
(-4.75%↓ Y/Y)
Net loss
-$5,982K
(-5.13%↓ Y/Y)
Cumulative preferred
dividends
$1,290K
(3.04%↑ Y/Y)
Operating loss
-$5,569K
(-9.84%↓ Y/Y)
Total other income
(expense), net
-$413K
(33.39%↑ Y/Y)
Net revenues
$51K
(-34.62%↓ Y/Y)
Change in fair value of
publicly traded warrant...
-$236K
(-837.50%↓ Y/Y)
Other income
(expense), net
$166K
(16700.00%↑ Y/Y)
Change in fair value of
forward purchase...
-$23K
(37.84%↑ Y/Y)
Total costs and
operating expenses
$5,620K
(9.17%↑ Y/Y)
Loss on offering and
change in fair value of...
$838K
Research and development
$3,132K
(26.04%↑ Y/Y)
General and
administrative
$2,029K
(-1.89%↓ Y/Y)
Cost of goods sold
$278K
(18.80%↑ Y/Y)
Sales and marketing
$181K
(-49.86%↓ Y/Y)
Buy us a coffee
Envoy Medical, Inc. (COCH)
Envoy Medical, Inc. (COCH)